MARKET

OCX

OCX

Oncocyte Corporation
NASDAQ
2.870
+0.030
+1.06%
After Hours: 2.860 -0.01 -0.35% 18:06 05/09 EDT
OPEN
2.870
PREV CLOSE
2.840
HIGH
2.960
LOW
2.811
VOLUME
63.47K
TURNOVER
--
52 WEEK HIGH
4.750
52 WEEK LOW
1.922
MARKET CAP
82.08M
P/E (TTM)
-0.6157
1D
5D
1M
3M
1Y
5Y
1D
New Strong Buy Stocks for May 6th
NASDAQ · 3d ago
Best Momentum Stocks to Buy for May 6th
Barchart · 3d ago
Weekly Report: what happened at OCX last week (0428-0502)?
Weekly Report · 4d ago
OncoCyte provides update on progress toward initiating clinical trial
TipRanks · 04/30 12:54
ONCOCYTE PROVIDES POSITIVE UPDATE ON CLINICAL TRIAL PROGRESS
Reuters · 04/30 12:30
OncoCyte announces new publication on transplant rejection assay
TipRanks · 04/29 12:42
Weekly Report: what happened at OCX last week (0421-0425)?
Weekly Report · 04/28 12:13
New Strong Buy Stocks for April 24th
NASDAQ · 04/24 10:31
More
About OCX
More
Oncocyte Corporation is a precision diagnostics company. The Company is engaged in the development of Oncocytes tests and the acquisition of proprietary molecular technologies in the fields of oncology and transplantation. The Company’s products include DetermaIO, VitaGraft, DetermaCNI and GraftAssure. DetermaIO is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. DetermaIO measures the expression level of 27 selected genes, which are interpreted through the use of a proprietary algorithm (patent pending) which computes a quantitative score (IO Score) that incorporates information from the immune inflammatory infiltrates within and around the tumor. Its pipeline test, DetermaCNI, is a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients. VitaGraft is a blood-based solid organ transplantation monitoring test. GraftAssure is a research use only blood-based solid organ transplantation monitoring test.
Recently
Symbol
Price
%Change
    DLR
  • 166.57
  • -0.08%

Webull offers OncoCyte Corp stock information, including NASDAQ: OCX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCX stock methods without spending real money on the virtual paper trading platform.